Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

Jennifer A. Quinn, Annick Desjardins, Jon Weingart, Henry Brem, M. Eileen Dolan, Shannon M. Delaney, James Vredenburgh, Jeremy Rich, Allan H. Friedman, David A. Reardon, John H. Sampson, Anthony E. Pegg, Robert C. Moschel, Robert Birch, Roger E. McLendon, James M. Provenzale, Sridharan Gururangan, Janet E. Dancey, Jill Maxwell, Sandra Tourt-UhligJames E. Herndon, Darell D. Bigner, Henry S. Friedman

Research output: Contribution to journalArticlepeer-review

179 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma'. Together they form a unique fingerprint.

Medicine & Life Sciences